TGR5 signaling reduces neuroinflammation during hepatic encephalopathy

Journal of Neurochemistry

Volumn 135, Issue 3, 2015, Pages 565-576

  McMillin, Matthew ^a,b   Frampton, Gabriel ^a,b   Tobin, Richard ^b   Dusio, Giuseppina ^b   Smith, Jenny ^b   Shin, Hope ^b   Newell Rogers, Karen ^b   Grant, Stephanie ^a,b   DeMorrow, Sharon ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

acute liver failure; azoxymethane; betulinic acid; GPBAR 1; IBA 1; microglia

Indexed keywords

AZOXYMETHANE; BETULIC ACID; CYCLIC AMP; CYTOKINE; G PROTEIN COUPLED RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROSTEROID; TAKEDA G PROTEIN COUPLED RECEPTOR 5; UNCLASSIFIED DRUG; GPBAR1 PROTEIN, MOUSE; TRITERPENE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FRONTAL CORTEX; HEPATIC ENCEPHALOPATHY; IN VITRO STUDY; MALE; MICROGLIA; MOUSE; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARACRINE SIGNALING; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION; AGONISTS; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; INFLAMMATION; METABOLISM; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; HEPATIC ENCEPHALOPATHY; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRITERPENES;

EID: 84945437553     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13243     Document Type: Article

References (49)

1. Ahboucha S., (2011) Neurosteroids and hepatic encephalopathy: an update on possible pathophysiologic mechanisms. Curr. Mol. Pharmacol. 4, 1-13.
2. Ahboucha S., and, Butterworth R. F., (2007) The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy. Metab. Brain Dis. 22, 291-308.
3. Ahboucha S., Layrargues G. P., Mamer O., and, Butterworth R. F., (2005) Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy. Ann. Neurol. 58, 169-170.
4. Ahboucha S., Jiang W., Chatauret N., Mamer O., Baker G. B., and, Butterworth R. F., (2008) Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis. Neurogastroenterol. Motil. 20, 949-957.
5. Belanger M., Desjardins P., Chatauret N., Rose C., and, Butterworth R. F., (2005) Mild hypothermia prevents brain edema and attenuates up-regulation of the astrocytic benzodiazepine receptor in experimental acute liver failure. J. Hepatol. 42, 694-699.
6. Bemeur C., Qu H., Desjardins P., and, Butterworth R. F., (2010) IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure. Neurochem. Int. 56, 213-215.
7. Bernal W., Hall C., Karvellas C. J., Auzinger G., Sizer E., and, Wendon J., (2007) Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 46, 1844-1852.
8. Butterworth R. F., (2011) Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 53, 1372-1376.
9. Cauli O., Mansouri M. T., Agusti A., and, Felipo V., (2009a) Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex. Gastroenterology 136, e1351-e1352.
10. Cauli O., Rodrigo R., Llansola M., et al,. (2009b) Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab. Brain Dis. 24, 69-80.
11. DeMorrow S., Glaser S., Francis H., Venter J., Vaculin B., Vaculin S., and, Alpini G., (2007) Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of fas and fas ligand to lipid rafts. J. Biol. Chem. 282, 13098-13113.
12. DeMorrow S., Francis H., Gaudio E., et al,. (2008) The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G1150-G1158.
13. D'Mello C., Le T., and, Swain M. G., (2009) Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J. Neurosci. 29, 2089-2102.
14. Ferenci P., Lockwood A., Mullen K., Tarter R., Weissenborn K., and, Blei A. T., (2002) Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35, 716-721.
15. Frampton G., Invernizzi P., Bernuzzi F., et al,. (2012) Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut 61, 268-277.
16. Genet C., Strehle A., Schmidt C., et al,. (2010) Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes. J. Med. Chem. 53, 178-190.
17. Gorg B., Qvartskhava N., Bidmon H. J., Palomero-Gallagher N., Kircheis G., Zilles K., and, Haussinger D., (2010) Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology 52, 256-265.
18. He J., Evans C. O., Hoffman S. W., Oyesiku N. M., and, Stein D. G., (2004) Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp. Neurol. 189, 404-412.
19. Heiss E. H., Kramer M. P., Atanasov A. G., Beres H., Schachner D., and, Dirsch V. M., (2014) Glycolytic switch in response to betulinic acid in non-cancer cells. PLoS ONE 9, e115683.
20. Itzhak Y., Roig-Cantisano A., Dombro R. S., and, Norenberg M. D., (1995) Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res. 705, 345-348.
21. Jiang W., Desjardins P., and, Butterworth R. F., (2009a) Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline. J. Neurochem. 109, 485-493.
22. Jiang W., Desjardins P., and, Butterworth R. F., (2009b) Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia. J. Cereb. Blood Flow Metab. 29, 944-952.
23. Jiang W., Desjardins P., and, Butterworth R. F., (2009c) Minocycline attenuates oxidative/nitrosative stress and cerebral complications of acute liver failure in rats. Neurochem. Int. 55, 601-605.
24. Jover R., Rodrigo R., Felipo V., et al,. (2006) Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: a model of hepatic encephalopathy in cirrhosis. Hepatology 43, 1257-1266.
25. Kawamata Y., Fujii R., Hosoya M., et al,. (2003) A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278, 9435-9440.
26. Keitel V., Donner M., Winandy S., Kubitz R., and, Haussinger D., (2008) Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem. Biophys. Res. Commun. 372, 78-84.
27. Keitel V., Gorg B., Bidmon H. J., Zemtsova I., Spomer L., Zilles K., and, Haussinger D., (2010) The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia 58, 1794-1805.
28. Ksontini R., Colagiovanni D. B., Josephs M. D., et al,. (1998) Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. J. Immunol. 160, 4082-4089.
29. Lavoie J., Layrargues G. P., and, Butterworth R. F., (1990) Increased densities of peripheral-type benzodiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopathy. Hepatology 11, 874-878.
30. Livak K. J., and, Schmittgen T. D., (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
31. Maruyama T., Tanaka K., Suzuki J., Miyoshi H., Harada N., Nakamura T., Miyamoto Y., Kanatani A., and, Tamai Y., (2006) Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. J. Endocrinol. 191, 197-205.
32. Matkowskyj K. A., Marrero J. A., Carroll R. E., Danilkovich A. V., Green R. M., and, Benya R. V., (1999) Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model. Am. J. Physiol. 277, G455-G462.
33. McMahan R. H., Wang X. X., Cheng L. L., et al,. (2013) Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease. J. Biol. Chem. 288, 11761-11770.
34. McMillin M., Frampton G., Thompson M., Galindo C., Standeford H., Whittington E., Alpini G., and, DeMorrow S., (2014a) Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline. J. Neuroinflammation 11, 121.
35. McMillin M., Galindo C., Pae H. Y., Frampton G., Di Patre P. L., Quinn M., Whittington E., and, DeMorrow S., (2014b) Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor beta1 in mice. J. Hepatol. 61, 1260-1266.
36. Norenberg M. D., Itzhak Y., and, Bender A. S., (1997) The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy. Adv. Exp. Med. Biol. 420, 95-111.
37. Quan H. Y., Kim do Y., Kim S. J., Jo H. K., Kim G. W., and, Chung S. H., (2013) Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway. Biochem. Pharmacol. 85, 1330-1340.
38. Rolando N., Harvey F., Brahm J., Philpott-Howard J., Alexander G., Gimson A., Casewell M., Fagan E., and, Williams R., (1990) Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 11, 49-53.
39. Rolando N., Wade J., Davalos M., Wendon J., Philpott-Howard J., and, Williams R., (2000) The systemic inflammatory response syndrome in acute liver failure. Hepatology 32, 734-739.
40. Schaap F. G., Trauner M., and, Jansen P. L., (2014) Bile acid receptors as targets for drug development. Nat. Rev. Gastroenterol. Hepatol. 11, 55-67.
41. Steinkamp-Fenske K., Bollinger L., Xu H., Yao Y., Horke S., Forstermann U., and, Li H., (2007) Reciprocal regulation of endothelial nitric-oxide synthase and NADPH oxidase by betulinic acid in human endothelial cells. J. Pharmacol. Exp. Ther. 322, 836-842.
42. Vaquero J., Polson J., Chung C., Helenowski I., Schiodt F. V., Reisch J., Lee W. M., and, Blei A. T., (2003) Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125, 755-764.
43. Vassileva G., Golovko A., Markowitz L., et al,. (2006) Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochem. J. 398, 423-430.
44. Walker W. S., Gatewood J., Olivas E., Askew D., and, Havenith C. E., (1995) Mouse microglial cell lines differing in constitutive and interferon-gamma-inducible antigen-presenting activities for naive and memory CD4 + and CD8 + T cells. J. Neuroimmunol. 63, 163-174.
45. Wan Y., Jiang S., Lian L. H., Bai T., Cui P. H., Sun X. T., Jin X. J., Wu Y. L., and, Nan J. X., (2013) Betulinic acid and betulin ameliorate acute ethanol-induced fatty liver via TLR4 and STAT3 in vivo and in vitro. Int. Immunopharmacol. 17, 184-190.
46. Wright G., Shawcross D., Olde Damink S. W., and, Jalan R., (2007) Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension. Metab. Brain Dis. 22, 375-388.
47. Yi J., Xia W., Wu J., Yuan L., Wu J., Tu D., Fang J., and, Tan Z., (2014) Betulinic acid prevents alcohol-induced liver damage by improving the antioxidant system in mice. J. Vet. Sci. 15, 141-148.
48. Yoneno K., Hisamatsu T., Shimamura K., et al,. (2013) TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease. Immunology 139, 19-29.
49. Zheng Z. W., Song S. Z., Wu Y. L., Lian L. H., Wan Y., and, Nan J. X., (2011) Betulinic acid prevention of d-galactosamine/lipopolysaccharide liver toxicity is triggered by activation of Bcl-2 and antioxidant mechanisms. J. Pharm. Pharmacol. 63, 572-578.